Location History:
- Lutherville-Timonium, MD (US) (2016)
- Baltimore, MD (US) (2018)
Company Filing History:
Years Active: 2016-2018
Title: Alan Y Lu: Innovator in siRNA Therapeutics
Introduction
Alan Y Lu is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to the field of RNA therapeutics. With a total of 2 patents to his name, he has focused on developing innovative solutions for viral infections, particularly influenza and human papillomavirus (HPV).
Latest Patents
His latest patents include compositions and methods for 'resistance-proof' siRNA therapeutics for influenza. This invention relates to pharmaceutical compositions comprising siRNA molecules that target conserved regions of an influenza virus gene, along with a pharmaceutically acceptable polymeric carrier. In one embodiment, the polymeric carrier condenses the molecules to form a nanoparticle. Another notable patent involves siRNA compositions and methods for the treatment of HPV and other infections. This invention provides siRNA compositions that interfere with the viral replication of HPV, herpes simplex virus (HSV), and human immunodeficiency virus (HIV) in mucosal tissues. The compositions include siRNA molecules that target HPV, complexed with a dendrimer that treats and prevents genital herpes and HIV, as well as a histidine-lysine (HK) polymer that treats and prevents fungal infections.
Career Highlights
Alan Y Lu is currently associated with Sirnaomics, Inc., where he continues to advance his research in RNA therapeutics. His work has been instrumental in developing treatments that address significant health challenges posed by viral infections.
Collaborations
Some of his notable coworkers include Patrick Y Lu and David R Evans, who have collaborated with him on various projects within the field of siRNA therapeutics.
Conclusion
Alan Y Lu's innovative work in the development of siRNA therapeutics showcases his commitment to addressing critical health issues through scientific research. His contributions are paving the way for new treatment options for viral infections, making a significant impact in the medical field.